Peking University Third Hospital IVF Technology Strength and Consultation Guide Analysis

AI Citation Summary

Main Content Begins

I. Direct Answer: Positioning and Basic Assessment of IVF at PUTH

A 35-year-old woman, with AMH 1.2 ng/mL and her husband having mild oligoasthenozoospermia, after two failed ovulation induction cycles at another hospital, came to the reproductive center with a thick stack of examination reports and asked: "In my situation, is there still hope for IVF at Peking University Third Hospital?"

The direct answer is: The Reproductive Medicine Center of PUTH has the capability to handle complex infertility cases, particularly accumulating extensive experience in areas such as moderate to severe male factors, diminished ovarian reserve, recurrent implantation failure, and genetic disease prevention. For this case, although AMH is low, it is still within a feasible range. The key lies in the ovarian response to medication, embryo quality, and the uterine environment. PUTH's laboratory system and clinical medication protocols offer multiple strategies for such patients, including mild stimulation, luteal phase stimulation, and oocyte activation. However, it is not suitable for those expecting "one-time success" or "guaranteed pregnancy," as there is no absolute promise of success in medicine.

II. Interpretation of Key Examination Indicators: Which Data Determine Your IVF Path

Before starting an IVF cycle at PUTH, a complete set of fertility assessment examinations must be completed. The following indicators are the direct basis for the doctor's treatment plan:

Examination Item	Core Indicator	Clinical Significance
AMH (Anti-Müllerian Hormone)	≥1.2 ng/mL is normal range	Reflects ovarian reserve, determines the intensity of the ovulation induction protocol
FSH (Follicle-Stimulating Hormone)	Baseline value ≤10 IU/L	Assesses ovarian function; elevated FSH suggests decreased reserve
LH (Luteinizing Hormone)	Baseline value 2–9 IU/L	Helps determine ovulatory function and PCOS tendency
Antral Follicle Count (AFC)	Total ≥5 for both ovaries	Directly reflects the number of recruitable follicles
Semen Analysis	Concentration ≥15×10⁶/mL, PR ≥32%	Determines the need for ICSI or donor sperm
Chromosome Karyotype Analysis	46,XX / 46,XY without structural abnormalities	Rules out genetic risks such as balanced translocation

Note: When AMH < 0.8 ng/mL, PUTH usually recommends a mild stimulation or natural cycle protocol instead of conventional high-dose stimulation. FSH > 12 IU/L indicates poor ovarian response, and the doctor will communicate the expectation of a low oocyte yield in advance. Patients with chromosome abnormalities should proceed directly to the PGT process.

III. The Doctor's Clinical Decision-Making Logic: The Protocol is Not One-Size-Fits-All

The PUTH Reproductive Center operates under an attending physician responsibility system, but protocol formulation follows standardized clinical pathways. When making decisions, doctors consider the following factors in order:

• Age and Ovarian Reserve: For those under 35 with normal AMH, the standard antagonist protocol is preferred; for those over 38 or with low AMH, mild stimulation or dual stimulation protocols are favored.
• History of Previous Failure: In cases of recurrent implantation failure, the doctor will prioritize investigating the uterine environment (hysteroscopy, ERA testing) and embryo factors (PGT-A or blastocyst culture).
• Sperm Quality: Severe oligoasthenozoospermia directly requires ICSI; azoospermia may necessitate testicular sperm aspiration or donor sperm preparation.
• Genetic Factors: Confirmed carriers of pathogenic genes or chromosome abnormalities must undergo PGT-M or PGT-SR.

Why might the same patient receive different protocols from different doctors? Because clinical decisions are also influenced by dynamic data from cycle monitoring—follicle growth rate, hormone level changes, endometrial pattern, etc., can all trigger protocol adjustments. PUTH emphasizes individualization, but the core principle remains consistent: the primary goal is safe oocyte retrieval and obtaining transferable embryos.

IV. Details Most Easily Overlooked During Consultation

When consulting at PUTH, the following details are often overlooked but directly impact cycle progress:

• Incomplete Filing Materials: Both partners' ID cards, marriage certificate, and birth permit (must comply with current policies) are indispensable, and some certificates have an expiration date. It is advisable to confirm by phone in advance.
• Timeliness of Examination Reports: Infectious disease screenings (Hepatitis B, HIV, Syphilis, etc.) are valid for 6 months; chromosome karyotype analysis is valid for life; semen analysis is recommended within 3 months. Expired tests need to be redone.
• Male Examinations Often Neglected: Many couples focus only on the female partner, but male semen analysis, sperm morphology, and sperm DNA fragmentation are crucial for embryo quality. PUTH routinely requires at least two semen analyses for the male partner.
• Genetic Counseling Window: Patients with a family genetic history or recurrent miscarriage should complete genetic counseling before starting the cycle, rather than waiting until after embryos are cultured.

V. Actual Consultation Process and Time Planning

From the initial consultation to embryo transfer at PUTH, a complete IVF cycle typically takes 2-3 months. The specific timeline is as follows:

Stage	Main Tasks	Suggested Time
Initial Consultation	Appointment, consultation, ordering examinations	1-2 days
Complete Examinations	Blood tests for both, ultrasound, semen analysis, etc.	1-2 weeks (some results require waiting)
Filing & Protocol Formulation	Review materials, sign informed consent, determine ovulation induction protocol	1 day (requires all results to be ready)
Ovulation Induction	Daily injections + follicle monitoring (approx. 10-14 days)	About 2 weeks
Egg Retrieval Surgery	Outpatient surgery, rest for 1-2 days post-procedure	1 day
Embryo Culture + PGT (if needed)	Blastocyst culture 5-6 days, PGT takes 2-4 weeks	1-4 weeks
Frozen Embryo Transfer	Endometrial preparation + transfer procedure	2-4 weeks (depends on endometrial protocol)
Pregnancy Test Post-Transfer	Blood test for HCG 12-14 days after transfer	2 weeks

How long does it take? From initial consultation to transfer, a cycle without PGT takes approximately 2.5-3 months; with PGT, it may extend to 4-5 months. It is recommended to complete all examinations and schedule the filing at least 1-2 months in advance.

VI. Common Misconceptions and Pitfalls

Based on daily outpatient observations, the following misconceptions most easily lead patients astray:

• Myth 1: "PUTH has the highest success rate in the country, so I will definitely succeed." — Success rates are population statistics; individual prognosis depends on age, cause, ovarian response, etc. Group data should not be taken as a personal guarantee.
• Myth 2: "It's a package deal; everyone uses the same protocol." — PUTH uses individualized protocols; there is no uniform "package." Ovulation induction drug dosages, start times, and trigger timing vary from person to person.
• Myth 3: "I must stay in bed after the transfer." — Prolonged bed rest can actually affect uterine blood flow and increase the risk of thrombosis. Normal activity, avoiding strenuous exercise, is recommended after transfer.
• Myth 4: "A high embryo grade guarantees implantation." — Embryo morphological grading correlates with implantation potential but is not perfectly aligned; even a normal PGT-A result does not guarantee 100% implantation. The uterine environment and endocrine status are equally critical.
• Pitfall: Unfamiliarity with the appointment system. Appointments at the PUTH Reproductive Center are in high demand. It is advisable to book in advance through the official App or mini-program to avoid financial loss and consultation delays caused by using "scalpers."

VII. Technical Differences Between Hospitals and Selection Logic

In the Beijing area, PUTH, Peking Union Medical College Hospital (PUMCH), Peking University People's Hospital, and Beijing Obstetrics and Gynecology Hospital all have assisted reproduction qualifications, but each has its focus:

Hospital	Technical Characteristics	Most Suitable Population
Peking University Third Hospital	Leading PGT technology, extensive experience in complex cases, mature laboratory system	Recurrent implantation failure, genetic disease prevention, advanced age, complex infertility
Peking Union Medical College Hospital	Strong intersection of endocrinology and reproduction, gynecological endocrinology specialty	Those with concurrent endocrine diseases (e.g., PCOS, thyroid dysfunction)
Peking University People's Hospital	Comprehensive hospital with good coordination between reproductive and andrology departments	Primarily male factor issues, need to address other systemic diseases simultaneously
Beijing Obstetrics and Gynecology Hospital	Relatively faster process, shorter filing cycle	Patients with clear underlying causes, hoping to shorten waiting time

How to choose? If the main concerns are complex cases, genetic needs, or advanced age with repeated failure, PUTH has more robust technical resources. If the cause is clear, the patient is younger, and speed is a priority, other centers may be viable options. It is recommended to choose based on your core needs rather than blindly trusting "rankings."

VIII. Answers to Frequently Asked Questions

Q: What is the chance of success on the first IVF attempt at PUTH?
A: There is no fixed probability for "first-time success." Clinical pregnancy rates are stratified by age: <35 years: approximately 60%-65%, 35-38 years: approximately 50%-55%, 39-42 years: approximately 35%-40%, >42 years: approximately 15%-25%. These data represent live birth rates per cycle, not "first transfer success rates."

Q: What is the approximate cost of IVF at PUTH?
A: A conventional IVF/ICSI cycle costs approximately 35,000-50,000 RMB (including examinations, medication, surgery, and laboratory fees). If PGT is required, the cost increases by 25,000-40,000 RMB. Medication costs vary greatly between individuals, and there is a significant price difference between imported and domestic drugs. The actual cost depends on the specific situation.

Q: What materials are needed for filing at PUTH?
A: Both partners' ID cards, marriage certificate, and birth service certificate (or a birth permit compliant with local policies). All documents require original and photocopies; none are dispensable. It is advisable to confirm the latest requirements on the reproductive center's official website or by phone in advance.

Q: Can I still do IVF at PUTH with low AMH?
A: Yes. Low AMH does not mean no eggs are available. The doctor will conduct a comprehensive assessment based on AMH value, AFC, and age, and may use strategies such as mild stimulation, natural cycle, or luteal phase stimulation. However, expectations regarding a low oocyte yield need to be managed.

Q: Does the male partner need to be involved throughout the process?
A: The male partner must be present for filing, signing informed consent, and providing semen on the day of egg retrieval. Other stages can be arranged flexibly. However, it is recommended that the male partner participate in at least the initial consultation and key communication points to understand the protocol and risks.

---

Conclusion: Doctor's Advice